Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.
Biocon falls even after subsidiary completes biosimilar integration before schedule on December 19, 2023 at 7:10 am
Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.